We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

By LabMedica International staff writers
Posted on 21 May 2025

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. More...

When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing for highly sensitive biodetection. However, a significant challenge in applying these sensors in real-world situations is that coupling light into them requires a tapered optical fiber with a diameter smaller than 2 microns. These tiny fibers are difficult to align and are sensitive to environmental disturbances. This limitation has hindered the integration of microlaser sensors into lab-on-a-chip devices for real-time, high-sensitivity detection of biomolecules. In response to this challenge, researchers have developed a 3D micro-printed sensor for highly sensitive on-chip biosensing. The sensor, which is based on a polymer whispering-gallery-mode microlaser, opens up new possibilities for high-performance, cost-effective lab-on-a-chip devices aimed at early disease detection.

In their research published in the journal Optics Letters, scientists at The Hong Kong Polytechnic University (PolyU, Hong Kong, China) have introduced a new microlaser sensor design that addresses many of the difficulties in integrating these sensors into lab-on-a-chip systems, making them suitable for point-of-care medical tests. The sensor utilizes a unique Limacon-shaped disk microcavity, which enables the detection of very small concentrations of human immunoglobulin G (IgG), a common antibody found in blood and other bodily fluids. Traditional whispering-gallery-mode microlasers use circular microcavities, but this design makes it challenging to efficiently collect the emitted light, which limits the sensor's signal clarity.

To overcome this limitation, the researchers designed a whispering-gallery-mode microlaser sensor featuring a Limacon-shaped suspended microdisk. This innovative design reduces the lasing threshold and produces directional light emission, enhancing efficiency and making it more suitable for integration into on-chip systems. Using their proprietary 3D micro-printing technology, which provides high resolution and flexibility, the researchers were able to quickly print arrays of whispering-gallery-mode microlaser biosensors. Experimental results demonstrated that the biosensors achieved a low lasing threshold of 3.87 μJ/mm2 and a narrow lasing linewidth of approximately 30 pm. Additionally, the sensors successfully detected IgG at a sensitivity level of attograms per milliliter, highlighting their potential for ultra-low detection of biomarkers for early disease diagnosis. Looking ahead, the researchers aim to integrate these microlaser sensors into a microfluidic chip to develop optofluidic biochips capable of rapidly and simultaneously detecting multiple disease biomarkers.

“In the future, these whispering-gallery-mode microlaser sensors could be integrated into a microfluidic chip to enable a new generation of lab-on-chip devices for ultrasensitive quantitative detection of multiple biomarkers,” said research team leader A. Ping Zhang from The Hong Kong Polytechnic University. “This could be used for early diagnosis of diseases such as cancers and Alzheimer's disease or for fighting major health crises, such as the COVID-19 pandemic.”

Related Links:
PolyU


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.